Cargando…
Nanophotosensitive drugs for light-based cancer therapy: what does the future hold?
Autores principales: | Tang, Rui, Habimana-Griffin, LeMoyne M, Lane, Daniel D., Egbulefu, Christopher, Achilefu, Samuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480785/ https://www.ncbi.nlm.nih.gov/pubmed/28447872 http://dx.doi.org/10.2217/nnm-2017-0077 |
Ejemplares similares
-
Multimodal fluorescence molecular imaging for in vivo characterization of skin cancer using endogenous and exogenous fluorophores
por: Miller, Jessica P., et al.
Publicado: (2017) -
Breaking the Depth Dependency of Phototherapy with Cerenkov Radiation and Low Radiance Responsive Nanophotosensitizers
por: Kotagiri, Nalinikanth, et al.
Publicado: (2015) -
Intracranial glioma xenograft model rapidly reestablishes blood–brain barrier integrity for longitudinal imaging of tumor progression using fluorescence molecular tomography and contrast agents
por: Habimana-Griffin, LeMoyne, et al.
Publicado: (2020) -
Advances for prosthetic technology: from historical perspective to current status to future application
por: LeMoyne, Robert
Publicado: (2016) -
Stem cells and other innovative intra-articular therapies for osteoarthritis: what does the future hold?
por: Singh, Jasvinder A
Publicado: (2012)